Home  |  Current Issue  |  Past Issues  |  Supplements


Supplement 5 to Volume 75, July 2008

Hyperuricemia and Gout:
Management Challenges and Solutions

Supplement Editor

Brian F. Mandell, MD, PhD
Cleveland Clinic

Contents

This supplement is based on the proceedings of a symposium, “The Hyperuricemia and Gout Summit,” held October 5, 2007, in Scottsdale, Ariz. All faculty presentations at the symposium were developed by the presenting physicians themselves. The symposium was organized logistically by Fallon Medica LLC, a medical communication company. Fallon Medica transcribed audio recordings of the symposium presentations and forwarded the transcripts to the respective physician presenters, who developed the transcripts into the articles published here without assistance from undeclared contributors. All but one of the articles underwent formatting and nonsubstantive copyediting by Fallon prior to submission to Cleveland Clinic Journal of Medicine. The Journal had all articles peer reviewed to ensure independence and freedom from bias.

Author and editor disclosures

From the editor:
Confessions of a goutophile: Despite its treatability, gout remains a problem

Brian F. Mandell, MD, PhD

The pathogenesis of gout
H. Ralph Schumacher, Jr, MD

Clinical manifestations of hyperuricemia and gout
Brian F. Mandell, MD, PhD

Epidemiology of gout
Arthur L. Weaver, MD, MS

The role of hyperuricemia and gout in kidney and cardiovascular disease
N. Lawrence Edwards, MD

The gout diagnosis
Robin K. Dore, MD

The practical management of gout
H. Ralph Schumacher, Jr, MD, and Lan X. Chen, MD, PhD

July
2008

Supplement 5
to Volume 75

This supplement and the symposium on which it is based were supported by educational grants from TAP Pharmaceutical Products Inc.

Guidelines for grant-supported supplements to the Cleveland Clinic Journal of Medicine